Working With Patient Advocacy Organizations to Inform Development

19 Jan 2023
11:00
Patient and Clinical Considerations Track

11:00am Chair Introduction

Sharon Hesterlee, Chief Research Officer, Muscular Dystrophy Association USA

 

11:05am Presentation: TBA

Tom Whitehead, Co-Founder, Emily Whitehead Foundation

 

11:20am Presentation: TBC

Speaker TBC

 

11:35am Presentation: TBA

Gwen Nichols, Chief Medical Officer, Leukemia and Lymphoma Society

 

11:50am Presentation: TBA

Anne Rowzee, Associate Director for Policy, OTAT, FDA

 

12:05pm Closing Panel with Q&A

With all session participants

Speakers

Anne Rowzee
Associate Director for Policy, Office of Tissues and Advanced Therapies
FDA
Gwen Nichols
Chief Medical Officer
The Leukemia & Lymphoma Society
Sharon Hesterlee
Executive Vice President, Chief Research Officer
Muscular Dystrophy Association USA